How to Refer a Patient
For urgent referrals or inpatient transfers, please call UAB MIST (Medical Information Service via Telephone) at 1-800-UAB-MIST (1-800-822-6478) or email firstname.lastname@example.org. UAB MIST is a toll-free, 24-hour service that connects physicians anywhere in the country with UAB Medicine specialists.
UAB Pulmonary Services is consistently recognized among the best programs of its kind by U.S. News & World Report. Our Asthma and COPD Clinic focuses on patients with emphysema, chronic bronchitis, and chronic asthma, while our Alpha-1 Clinic specializes in patients with alpha-1 antitrypsin deficiency. Our program is integrated with the UAB Lung Health Center, which offers new drugs and therapies through clinical research studies, and we perform advanced treatments such as bronchoscopic lung volume reduction and lung transplantation for qualifying patients. Telehealth services are available in some cases.
Online provider access to UAB electronic medical records
View all ongoing clinical trials at the University of Alabama at Birmingham.
- Endobronchial Lung Volume ReductionCME/CE0.25Minutes10Close
- Alpha-1 Antitrypsin Deficiency: Testing & Treatment OptionsCME/CE0.25Minutes16Close
- Bronchial ThermoplastyCME/CE0.00Minutes13Bronchial Thermoplasty (BT) is an FDA approved procedure for adult patients with severe asthma who remain poorly controlled despite compliance with medical therapy. BT employs heat, delivered by thin wires fed down the airway, to reduce the amount of excess smooth muscle in the airway.WatchClose
- Semi-Interventional PulmonologyCME/CE0.00Minutes22Mark Dransfield MD, covers two major topics in this presentation from the 2013 UAB Pulmonary and Critical Care Update symposium. Bronchial thermoplasty offers help to those asthma patients who are unable to be adequately controlled despite available medications.WatchClose
- COPD in the 21st CenturyCME/CE0.00Minutes51Mark Dransfield, MD, professor of medicine in the Division of Pulmonary, Allergy & Critical Care Medicine, discusses the clinical and molecular phenotyping, current ongoing clinical trials, the heterogeneity of acute exacerbations, and the future of research in chronic obstructive pulmonary disease (COPD).WatchClose